President Joe Biden has approved deals with drug companies to lower the costs of 10 of Medicare’s most common and expensive drugs.
Medicare released its new drug prices for 2026, and many of the costliest prescriptions are set to be lowered for Americans who rely on the government health insurance.
President Joe Biden has approved deals with drug companies to lower the costs of 10 of Medicare’s most common and expensive drugs.
The Biden administration said that the new prices would save taxpayers about $6 billion, while the seniors on Medicare could save $1.5 billion on their prescriptions.
«For years, millions of Americans were forced to choose between paying for medications or putting food on the table, while Big Pharma blocked Medicare from being able to negotiate prices on behalf of seniors and people with disabilities. But we fought back—and won», Biden said in a statement.
«Today, for the first time in history, my Administration is announcing that Medicare has reached agreements on new, lower prices with the manufacturers of all 10 drugs selected for the first round of drug price negotiation.»
The affected medications include those Americans use to manage diabetes, cancer and heart disease, which affect millions each year.
For the 10 medications, Medicare recipients will save between 38 and 79 percent starting in 2026. The drugs include Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and Fiasp.
Blood clot medications Eliquis and Xarelto went down to $231 and $197, while diabetes medications got major savings too.
Jardiance, Januvia, Farxiga and Fiasp shaved hundreds off their list prices for 2026, now costing between $100 and $200 compared to previous costs above $500 for a 30-day supply.
